Suppr超能文献

人类效应B细胞上皮肤淋巴细胞抗原的表达取决于抗原接触的部位和性质。

Cutaneous lymphocyte antigen expression on human effector B cells depends on the site and on the nature of antigen encounter.

作者信息

Kantele Anu, Savilahti Erkki, Tiimonen Heidi, Iikkanen Katja, Autio Soile, Kantele Jussi M

机构信息

Division of Infectious Diseases, Department of Medicine, Helsinki University Central Hospital, Helsinki, Finland.

出版信息

Eur J Immunol. 2003 Dec;33(12):3275-83. doi: 10.1002/eji.200324311.

Abstract

In contrast to T cells, information on skin-homing B cells expressing the cutaneous lymphocyte antigen (CLA) is sparse. CLA expression on human B cells was investigated among circulating immunoglobulin-secreting cells (ISC) and among antigen-specific antibody-secreting cells (ASC) elicited by parenteral, oral or rectal primary immunization, or by parenteral or oral secondary immunization with Salmonella typhi Ty21a. CLA expression was examined by combining cell sorting with an enzyme-linked immunospot assay. Among all ISC, the proportion of CLA(+) cells was 13-21%. Parenteral immunization induced antigen-specific ASC of which 13% were CLA(+), while oral and rectal immunizations were followed by only 1% of CLA(+) ASC (p<0.001). Oral re-immunization was followed by an up-regulation of CLA (34-48%) regardless of the route of priming. Parenteral re-immunization elicited ASC of which 9-14% were CLA(+). In conclusion, the expression of CLA on human effector B cells depends on the site of antigen encounter: intestinal stimulation elicits cells with no CLA, while parenteral encounter elicits significant numbers of CLA(+) cells. Even though primary antigen encounter in the intestine failed to stimulate CLA expression, up-regulation of CLA was found upon intestinal antigen re-encounter. These findings may be of relevance in the pathogenesis of some cutaneous disorders.

摘要

与T细胞不同,关于表达皮肤淋巴细胞抗原(CLA)的皮肤归巢B细胞的信息很少。在循环免疫球蛋白分泌细胞(ISC)以及经肠胃外、口服或直肠初次免疫,或用伤寒沙门氏菌Ty21a进行肠胃外或口服二次免疫诱导产生的抗原特异性抗体分泌细胞(ASC)中,研究了人B细胞上CLA的表达情况。通过将细胞分选与酶联免疫斑点测定相结合来检测CLA的表达。在所有ISC中,CLA(+)细胞的比例为13%-21%。肠胃外免疫诱导产生的抗原特异性ASC中,13%为CLA(+),而口服和直肠免疫后,CLA(+)ASC仅占1%(p<0.001)。无论初次免疫途径如何,口服再次免疫后CLA表达上调(34%-48%)。肠胃外再次免疫诱导产生的ASC中,9%-14%为CLA(+)。总之,人效应B细胞上CLA的表达取决于抗原接触部位:肠道刺激引发的细胞不表达CLA,而肠胃外接触引发大量CLA(+)细胞。尽管肠道初次抗原接触未能刺激CLA表达,但再次接触肠道抗原时发现CLA表达上调。这些发现可能与某些皮肤疾病的发病机制有关。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验